F&G ANNUITIES & LIFE INC(FG)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FG F&G ANNUITIES & LIFE INC

交易中 08-19 12:17:02 EDT

41.27

-0.11

-0.28%

最高41.77	最低41.19	成交量8,621
今开41.43	昨收41.38	日振幅1.40%
总市值52.03亿	流通市值7.20亿	总股本1.26亿
成交额35.70万	换手率0.05%	流通股本1,744万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FG","market":"US","secType":"STK","nameCN":"F&G ANNUITIES & LIFE INC","latestPrice":41.265,"timestamp":1724084214732,"preClose":41.38,"halted":0,"volume":8621,"delay":0,"floatShares":17441812,"shares":126098548,"eps":2.558704,"marketStatus":"交易中","marketStatusCode":2,"change":-0.115,"latestTime":"08-19 12:17:02 EDT","open":41.43,"high":41.77,"low":41.19,"amount":357040.930597,"amplitude":0.014016,"askPrice":41.39,"askSize":16,"bidPrice":41.1,"bidSize":1,"shortable":3,"etf":0,"ttmEps":2.558704,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1724097600000},"adr":0,"adjPreClose":41.38,"adrRate":0,"dividendRate":0.020356,"postHourTrading":{"tag":"盘后","latestPrice":41.38,"preClose":41.38,"latestTime":"16:02 EDT","volume":3876,"amount":160388.88,"timestamp":1723838573706},"volumeRatio":0.279257,"impliedVol":0.4554,"impliedVolPercentile":0.6494},"requestUrl":"/m/hq/s/FG/tweets","defaultTab":"tweets","newsList":[{"id":"2459860471","title":"F&G Annuities & Life, Inc.盘中异动 早盘大幅拉升5.30%报40.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459860471","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459860471?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:48","pubTimestamp":1723733323,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时48分，F&G Annuities & Life, Inc.股票出现波动，股价大幅上涨5.30%。F&G Annuities & Life, Inc.股票所在的保险行业中，整体涨幅为0.54%。其相关个股中，Abacus Life Inc C/Wts 30/06/2028 、天睿祥、F&G Annuities & Life, Inc.涨幅较大，Heritage Insurance Holdings, Inc.、Root, Inc.、Fidelis Insurance Holdings Limited较为活跃，换手率分别为1.06%、0.62%、0.48%，振幅较大的相关个股有Abacus Life Inc C/Wts 30/06/2028 、Fidelis Insurance Holdings Limited、Fundamental Global Inc.，振幅分别为11.39%、8.55%、6.97%。F&G Annuities & Life, Inc.公司简介：F&G Annuities & Life Inc是一家为零售年金和人寿保险客户以及机构客户提供保险解决方案的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815224844ab5ddb6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815224844ab5ddb6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","FG","BK4162","PRT"],"gpt_icon":0},{"id":"2458692718","title":"F&G Annuities & Life, Inc.2024财年第二财季实现净利润2.03亿美元，同比增加56.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458692718","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458692718?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:05","pubTimestamp":1723392347,"startTime":"0","endTime":"0","summary":"8月12日，F&G Annuities & Life, Inc.公布财报，公告显示公司2024财年第二财季净利润为2.03亿美元，同比增加56.15%；其中营业收入为11.95亿美元，同比增加0.50%，每股基本收益为1.60美元。从资产负债表来看，F&G Annuities & Life, Inc.总负债636.93亿美元，其中短期债务3.57亿美元，资产负债比为1.06，流动比率为0.11。机构评级：截至2024年8月12日，当前有3家机构对F&G Annuities & Life, Inc.目标价做出预测，其中目标均价为42.33美元，其中最低目标价为40.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120005599f2222b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120005599f2222b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FG"],"gpt_icon":0},{"id":"2457408249","title":"F&G Annuities & Life Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457408249","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457408249?lang=zh_cn&edition=full","pubTime":"2024-08-06 06:40","pubTimestamp":1722897646,"startTime":"0","endTime":"0","summary":"   * F&G Annuities & Life Inc   公布的截至6月底的季度调整后每股收益为1.06美元，高于去年同期的每股收益63美分。两位分析师对该季度的平均预期为每股收益 1.09 美元。华尔街预期为每股收益 98 美分至 1.19 美元。* F&G Annuities & Life Inc 公布的季度每股收益为 1.51 美元。* 该公司报告的季度净收入为 1.98 亿美元。* F&G Annuities & Life Inc 本季度股价上涨了 0.6%，今年迄今为止下跌了 16.8%。华尔街对 F&G Annuities & Life Inc 的 12 个月目标价中位数为 42.50 美元。本摘要由 LSEG 8 月 5 日 10:40 p.m. UTC 调制解调器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"F&G Annuities & Life Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4162","FG"],"gpt_icon":0},{"id":"2457756547","title":"F&G Annuities & Life, Inc.盘中异动 快速下挫5.75%报36.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457756547","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457756547?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:35","pubTimestamp":1722864925,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时35分，F&G Annuities & Life, Inc.股票出现异动，股价大幅下挫5.75%。F&G Annuities & Life, Inc.股票所在的保险行业中，整体跌幅为3.37%。其相关个股中，Fundamental Global Inc.、威达信、Fundamental Global Inc 8.00% Cum Pre Stk Series A涨幅较大，Reliance Global Group, Inc.、天睿祥、Trupanion, Inc.较为活跃，换手率分别为1.10%、0.44%、0.30%，振幅较大的相关个股有Fundamental Global Inc.、Reliance Global Group, Inc.、Gohealth, Inc.，振幅分别为12.00%、8.06%、6.65%。F&G Annuities & Life, Inc.公司简介：F&G Annuities & Life Inc是一家为零售年金和人寿保险客户以及机构客户提供保险解决方案的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213525af95fa64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213525af95fa64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","BK4162","PRT","FG"],"gpt_icon":0},{"id":"2456263937","title":"F&G Annuities & Life Inc   预计每股收益1.09美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456263937","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456263937?lang=zh_cn&edition=full","pubTime":"2024-08-03 05:02","pubTimestamp":1722632540,"startTime":"0","endTime":"0","summary":"   * F&G Annuities & Life Inc    将于8月5日公布截至2024年6月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于爱荷华州得梅因的公司的营收将从去年同期的11.7亿美元增长10.6%，达到12.92亿美元。* LSEG 分析师对 F&G Annuities & Life Inc 的平均预期为每股收益 1.09 美元。* 华尔街对 F&G Annuities & Life Inc 的 12 个月目标价中位数为 42.50 美元，高于上一交易日的收盘价 38.29 美元。8月2日 - 本摘要于北京时间 8 月 2 日 21:02 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FG"],"gpt_icon":0},{"id":"2456828770","title":"F&G Annuities & Life, Inc.盘中异动 早盘股价大跌6.15%报38.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456828770","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456828770?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:11","pubTimestamp":1722607888,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时11分，F&G Annuities & Life, Inc.股票出现波动，股价急速下挫6.15%。F&G Annuities & Life, Inc.股票所在的保险行业中，整体涨幅为0.05%。其相关个股中，Ryan Specialty Holdings, Inc.、汉诺威保险、Bowhead Specialty Holdings Inc.涨幅较大，Reliance Global Group, Inc.、Lemonade, Inc.、天睿祥较为活跃，换手率分别为1.08%、0.52%、0.42%，振幅较大的相关个股有Root, Inc.、林肯国民、Ryan Specialty Holdings, Inc.，振幅分别为7.91%、6.59%、6.57%。F&G Annuities & Life, Inc.公司简介：F&G Annuities & Life Inc是一家为零售年金和人寿保险客户以及机构客户提供保险解决方案的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802221128af95a80b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802221128af95a80b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","PRT","BK4162","FG"],"gpt_icon":0},{"id":"2456589704","title":"F&G Annuities & Life, Inc.盘中异动 临近午盘大幅下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456589704","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456589704?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:46","pubTimestamp":1722527177,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时46分，F&G Annuities & Life, Inc.股票出现波动，股价快速下跌5.12%。F&G Annuities & Life, Inc.股票所在的保险行业中，整体跌幅为1.03%。其相关个股中，Oxbridge Re Holdings C/Wts 26/03/2029、美国家庭寿险、公民保险涨幅较大，Reliance Global Group, Inc.、Lemonade, Inc.、林肯国民较为活跃，换手率分别为1.54%、1.54%、0.83%，振幅较大的相关个股有Oxbridge Re Holdings C/Wts 26/03/2029、Tiptree Inc.、Root, Inc.，振幅分别为28.74%、9.87%、9.78%。F&G Annuities & Life, Inc.公司简介：F&G Annuities & Life Inc是一家为零售年金和人寿保险客户以及机构客户提供保险解决方案的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801234617971987b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801234617971987b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRT","BK4162","BK4213","FG"],"gpt_icon":0},{"id":"2450367669","title":"F&G Annuities & Life, Inc.盘中异动 临近午盘股价大涨5.00%报42.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450367669","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450367669?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:45","pubTimestamp":1720712731,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时45分，F&G Annuities & Life, Inc.股票出现异动，股价快速上涨5.00%。截至发稿，该股报42.00美元/股，成交量1.4167万股，换手率0.01%，振幅3.01%。F&G Annuities & Life, Inc.股票所在的保险行业中，整体涨幅为0.39%。F&G Annuities & Life, Inc.公司简介：F&G Annuities & Life Inc是一家为零售年金和人寿保险客户以及机构客户提供保险解决方案的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711234532af91e228&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711234532af91e228&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","PRT","BK4162","FG"],"gpt_icon":0},{"id":"2450877840","title":"F&G Annuities & Life, Inc.盘中异动 快速拉升5.01%报39.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450877840","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450877840?lang=zh_cn&edition=full","pubTime":"2024-07-11 03:55","pubTimestamp":1720641314,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日03时55分，F&G Annuities & Life, Inc.股票出现波动，股价快速拉升5.01%。截至发稿，该股报39.86美元/股，成交量4.6487万股，换手率0.04%，振幅3.87%。F&G Annuities & Life, Inc.股票所在的保险行业中，整体涨幅为0.44%。F&G Annuities & Life, Inc.公司简介：F&G Annuities & Life Inc是一家为零售年金和人寿保险客户以及机构客户提供保险解决方案的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110355149681b9ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110355149681b9ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","BK4162","FG","PRT"],"gpt_icon":0},{"id":"2444481397","title":"FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2444481397","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444481397?lang=zh_cn&edition=full","pubTime":"2024-06-18 20:00","pubTimestamp":1718712000,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, June  18, 2024  (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host the second part of its virtual KOL investor event series on Wednesday, June 26, 2024 at 10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/18/2900347/33525/en/FibroGen-to-Host-Part-II-of-Virtual-KOL-Investor-Event-Series-to-Review-FG-3246-Development-Program-in-Metastatic-Castration-Resistant-Prostate-Cancer-on-June-26-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4218","BK4588","FGEN","ADC","BK4080","BK4162","CIA","BK4181","HST","BK4192","KOL","BK4231","BK4585","BK4505","PET","FG"],"gpt_icon":0},{"id":"2443500894","title":"艾伯维和明济生物制药（北京）有限公司宣布签署一项许可协议共同开发FG-M701。FG-M701是正处于临床前开发阶段的一种用于治疗炎症性肠病（IBD）的下一代TL1A抗体。","url":"https://stock-news.laohu8.com/highlight/detail?id=2443500894","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443500894?lang=zh_cn&edition=full","pubTime":"2024-06-13 20:20","pubTimestamp":1718281230,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FG","BK4162","IBD"],"gpt_icon":0},{"id":"2443502452","title":"根据协议条款艾伯维公司将获得独家全球许可开发、制造和商业化FG-M701。","url":"https://stock-news.laohu8.com/highlight/detail?id=2443502452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443502452?lang=zh_cn&edition=full","pubTime":"2024-06-13 19:59","pubTimestamp":1718279962,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0158827948.USD","LU0211328371.USD","LU1718418525.SGD","BK4585","LU1291159041.SGD","LU0234572021.USD","LU1732800096.USD","LU0170899867.USD","LU0417517546.SGD","BK4534","LU1585245621.USD","LU0820561818.USD","BK4162","LU0795875086.SGD","LU0985320562.USD","LU0795875169.SGD","LU1496350502.SGD","LU1267930490.SGD","LU0820561909.HKD","LU1430594728.SGD","LU1244550494.USD","BK4533","FG","ABBV","LU0234570918.USD","LU0661504455.SGD","LU1244550221.USD","LU0912757837.SGD","LU0456855351.SGD","LU0943347566.SGD","BK4581","LU0689472784.USD","BK4139","LU1244550577.SGD","LU0198837287.USD","BK4588","LU1496350171.SGD","LU1093756168.USD","IE0009355771.USD","LU0029864427.USD","LU0310800379.SGD","IE00B2B36J28.USD","LU0114720955.EUR","LU0949170772.SGD","LU1023059063.AUD","LU0738911758.USD","IE00BSNM7G36.USD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2441513719","title":"Gv宣布与Abb-FG合作进行Tokenization","url":"https://stock-news.laohu8.com/highlight/detail?id=2441513719","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441513719?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:30","pubTimestamp":1717677006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FG","BK4162"],"gpt_icon":0},{"id":"2440412102","title":"FibroGen股票在收盘后上涨40%报1.73美元宣布获得FG-3165用于治疗实体肿瘤患者的临床研究药物申请获得FDA认可。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440412102","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440412102?lang=zh_cn&edition=full","pubTime":"2024-06-04 04:09","pubTimestamp":1717445358,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FG","BK4162"],"gpt_icon":0},{"id":"2440412480","title":"FibroGen公司- FG-3165和FG-3175在临床前研究中已经证明与PD-1抑制剂具有互补的作用机制。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440412480","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440412480?lang=zh_cn&edition=full","pubTime":"2024-06-04 04:06","pubTimestamp":1717445185,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PD","BK4162","BK4023","LU1169590202.USD","LU1169589451.USD","FG"],"gpt_icon":0},{"id":"2440741297","title":"Fibrogen宣布与再生元制药公司签署临床试验供应协议评估FG-3165（抗半乳糖凝集素9）和FG-3175（抗Ccr8）等其免疫肿瘤资产在即将进行的临床试验中与Libtayo®联合使用。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440741297","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440741297?lang=zh_cn&edition=full","pubTime":"2024-06-04 04:05","pubTimestamp":1717445100,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU2362541273.HKD","BK1576","LU2023250504.SGD","LU0058720904.USD","LU1974910355.USD","BK1583","BK4162","LU0289739699.SGD","REGN","LU2362540622.SGD","FG","LU0889565916.HKD","LU2362541513.USD","BK4588","BK4139","03347","LU0114720955.EUR","LU1917777945.USD","BK1141","LU0882574055.USD","LU2106854487.HKD","LU0053666078.USD","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2440514412","title":"Fibrogen宣布FG-3165的新药申请已经获得FDA清除这是一种靶向Galectin-9单克隆抗体用于治疗实体肿瘤患者。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440514412","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440514412?lang=zh_cn&edition=full","pubTime":"2024-06-04 04:02","pubTimestamp":1717444979,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FG","BK4162"],"gpt_icon":0},{"id":"2440412543","title":"FibroGen公司 - FG-3165的安全性和效果将在选择性实体瘤的1期试验中评估。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440412543","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440412543?lang=zh_cn&edition=full","pubTime":"2024-06-04 04:02","pubTimestamp":1717444979,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FG","BK4162"],"gpt_icon":0},{"id":"2440125644","title":"FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2440125644","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440125644?lang=zh_cn&edition=full","pubTime":"2024-06-04 04:02","pubTimestamp":1717444920,"startTime":"0","endTime":"0","summary":"The safety and efficacy of FG-3165 will be evaluated in a Phase 1 trial in select solid tumorsPlan to begin enrollment in 2H 2024 SAN FRANCISCO, June  03, 2024  (GLOBE NEWSWIRE) -- FibroGen, Inc.(NASD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/03/2892568/33525/en/FibroGen-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-FG-3165-a-Galectin-9-Targeting-Monoclonal-Antibody-for-the-Treatment-of-Patients-with-Solid-Tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4162","FGEN","FG","ADC","BK4231","BK4505","CIA","BK4139","BK4080"],"gpt_icon":0},{"id":"2437711473","title":"FibroGen Inc-预计将于 2024 年下半年在 Mcrpc 启动 FG-3246 的 2 期单一疗法剂量优化研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2437711473","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437711473?lang=zh_cn&edition=full","pubTime":"2024-05-24 05:14","pubTimestamp":1716498899,"startTime":"0","endTime":"0","summary":"FibroGen Inc-预计将于 2024 年下半年在 Mcrpc 启动 FG-3246 的 2 期单一疗法剂量优化研究","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052405150395553536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052405150395553536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4162","BK4139","FG","BK4505","FGEN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fglife.com","stockEarnings":[{"period":"1week","weight":0.079},{"period":"1month","weight":-0.0792},{"period":"3month","weight":-0.0323},{"period":"6month","weight":-0.0716},{"period":"1year","weight":0.4113},{"period":"ytd","weight":-0.1004}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"F&G Annuities & Life, Inc.是一家特拉华州公司，成立于2020年8月7日，经过一系列重组，通过Fidelity National Financial, Inc.于2020年11月26日（纽约证券交易所代码：FNF）（“FNF”）之间的出资协议成为合并财务报表的母公司。他们提供保险解决方案并发行广泛的年金和人寿保险产品组合，包括延期年金（固定指数和固定利率年金）、即时年金和指数万能寿险（“IUL”）保险 ，通过他们的零售分销渠道。他们还通过机构渠道提供资金协议和养老金风险转移（“PRT”）解决方案。","exchange":"NYSE","name":"F&G ANNUITIES & LIFE INC","nameEN":"F&G ANNUITIES & LIFE INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"F&G ANNUITIES & LIFE INC(FG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供F&G ANNUITIES & LIFE INC(FG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"F&G ANNUITIES & LIFE INC,FG,F&G ANNUITIES & LIFE INC股票,F&G ANNUITIES & LIFE INC股票老虎,F&G ANNUITIES & LIFE INC股票老虎国际,F&G ANNUITIES & LIFE INC行情,F&G ANNUITIES & LIFE INC股票行情,F&G ANNUITIES & LIFE INC股价,F&G ANNUITIES & LIFE INC股市,F&G ANNUITIES & LIFE INC股票价格,F&G ANNUITIES & LIFE INC股票交易,F&G ANNUITIES & LIFE INC股票购买,F&G ANNUITIES & LIFE INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"F&G ANNUITIES & LIFE INC(FG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供F&G ANNUITIES & LIFE INC(FG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况